For citations:
Ignatiev V.G., Mikhailova V.M., Dyagileva T.S., Holtosunov I.A., Krivoshapkina L.A. The application experience of Simponi (Golimumab) in the second line of biological therapy after Infliximab) in the patient with ulcerative colitis. Yakut Medical Journal. 2016;(4):75-77.
Views PDF (Eng): 0